BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 8602137)

  • 1. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
    Lary JM; Edmonds LD
    MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994.
    Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH
    MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
    Williams LJ; Rasmussen SA; Flores A; Kirby RS; Edmonds LD
    Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in neural tube defects 1980-1989.
    Bower C; Raymond M; Lumley J; Bury G
    Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural tube defects: Prevalence, mortality, and maternal characteristics in two departmental hospitals in the northwestern region of Nicaragua, 2006-2018.
    Pastora Bucardo DM; González F; Montes Pastora M; Pimienta Ramirez PA; Bonilla IL; Vielot NA; Finnell RH
    Birth Defects Res; 2023 May; 115(9):945-953. PubMed ID: 37025002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spina bifida and anencephaly prevalence--United States, 1991-2001.
    Mathews TJ; Honein MA; Erickson JD
    MMWR Recomm Rep; 2002 Sep; 51(RR-13):9-11. PubMed ID: 12353510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in prevalence of neural tube defects in a high-risk region of the United States.
    Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S
    Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High burden of neural tube defects in Tigray, Northern Ethiopia: Hospital-based study.
    Berihu BA; Welderufael AL; Berhe Y; Magana T; Mulugeta A; Asfaw S; Gebreselassie K
    PLoS One; 2018; 13(11):e0206212. PubMed ID: 30427877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing epidemiology of neural tube defects. United States, 1968-1989.
    Yen IH; Khoury MJ; Erickson JD; James LM; Waters GD; Berry RJ
    Am J Dis Child; 1992 Jul; 146(7):857-61. PubMed ID: 1496959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.
    Boulet SL; Yang Q; Mai C; Kirby RS; Collins JS; Robbins JM; Meyer R; Canfield MA; Mulinare J;
    Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):527-32. PubMed ID: 18481813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.
    Atta CA; Fiest KM; Frolkis AD; Jette N; Pringsheim T; St Germaine-Smith C; Rajapakse T; Kaplan GG; Metcalfe A
    Am J Public Health; 2016 Jan; 106(1):e24-34. PubMed ID: 26562127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
    Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
    Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 57(53):1409-13. PubMed ID: 19129744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.
    Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic patterns in spina bifida birth prevalence trends--North Carolina, 1995-1999.
    Meyer RE; Siega-Riz AM
    MMWR Recomm Rep; 2002 Sep; 51(RR-13):12-5. PubMed ID: 12353507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spina bifida and other neural tube defects.
    Northrup H; Volcik KA
    Curr Probl Pediatr; 2000; 30(10):313-32. PubMed ID: 11147289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid and the decline in neural tube defects in Arkansas.
    Mosley BS; Hobbs CA; Flowers BS; Smith V; Robbins JM
    J Ark Med Soc; 2007 Apr; 103(10):247-50. PubMed ID: 17487022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural tube defect diagnosis and outcomes at a tertiary South African hospital with intensive case ascertainment.
    Krzesinski EI; Geerts L; Urban MF
    S Afr Med J; 2019 Aug; 109(9):698-703. PubMed ID: 31635597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.